Warning: The NCBI web site requires JavaScript to function. more...
Using information technology to transfer knowledge: a medical institution steps up to the plate.
Badgett R, Mulrow C.
Ann Intern Med. 2005 Feb 1;142(3):220-1. No abstract available. PMID: 15684213 [PubMed - indexed for MEDLINE]Related articlesFree article
Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providers.
Jain A, Atreja A, Harris CM, Lehmann M, Burns J, Young J.
Ann Intern Med. 2005 Feb 1;142(3):182-6.PMID: 15684206 [PubMed - indexed for MEDLINE]Related articlesFree article
Was Vioxx really that dangerous?
Park A.
Time. 2005 Feb 28;165(9):52. No abstract available. PMID: 15765852 [PubMed - indexed for MEDLINE]Related articles
Merck withdraws Vioxx; FDA issues public health advisory.
[No authors listed]
FDA Consum. 2004 Nov-Dec;38(6):11. No abstract available. PMID: 15675020 [PubMed - indexed for MEDLINE]Related articlesFree article
Ten lessons to be learned from the withdrawal of Vioxx (rofecoxib).
Carné X, Cruz N.
Eur J Epidemiol. 2005;20(2):127-9. No abstract available. PMID: 15792277 [PubMed - indexed for MEDLINE]Related articles
The changing landscape for COX-2 inhibitors: a summary of recent events.
Mamdani M.
Healthc Q. 2005;8(2):24, 26. No abstract available. PMID: 15828561 [PubMed - indexed for MEDLINE]Related articlesFree article
Stepping into the Vioxx void. Answers to four questions after the popular pain reliever was yanked off the market.
Harv Health Lett. 2005 Jan;30(3):6. No abstract available. PMID: 15773006 [PubMed - indexed for MEDLINE]Related articles
The Vioxx debacle.
Alpert JS.
Am J Med. 2005 Mar;118(3):203-4. No abstract available. PMID: 15745713 [PubMed - indexed for MEDLINE]Related articles
[Vision impairment by COX-2 inhibitor and the sequelae of voluntary Vioxx recall]
Meyer CH.
Klin Monbl Augenheilkd. 2005 Jan;222(1):62-3. German. No abstract available. PMID: 15678404 [PubMed - indexed for MEDLINE]Related articles
Vioxx, the implosion of Merck, and aftershocks at the FDA.
Horton R.
Lancet. 2004 Dec 4-10;364(9450):1995-6. No abstract available. PMID: 15582041 [PubMed - indexed for MEDLINE]Related articles
Discontinuation of Vioxx.
McLean TR.
Lancet. 2005 Jan 1-7;365(9453):25; author reply 27-8. No abstract available. PMID: 15639673 [PubMed - indexed for MEDLINE]Related articles
Garattini S, Bertelé V.
Lancet. 2005 Jan 1-7;365(9453):24. No abstract available. PMID: 15639671 [PubMed - indexed for MEDLINE]Related articles
Nutt DJ.
Lancet. 2005 Jan 1-7;365(9453):28. No abstract available. PMID: 15639676 [PubMed - indexed for MEDLINE]Related articles
Boers M.
Lancet. 2005 Jan 1-7;365(9453):25-6; author reply 26-7. No abstract available. PMID: 15639672 [PubMed - indexed for MEDLINE]Related articles
Cyclooxygenase-2 inhibitors and cardiovascular risk.
Smith ER.
Can J Cardiol. 2005 Mar;21(3):307-8. English, French. No abstract available. PMID: 15776124 [PubMed - indexed for MEDLINE]Related articles
Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
Nelson M, Cicuttini F.
Aust Fam Physician. 2004 Dec;33(12):965-6. No abstract available. PMID: 15630913 [PubMed - indexed for MEDLINE]Related articlesFree article
[Probable cardiac failure due to rofecoxib]
García Nicolás FJ.
Aten Primaria. 2005 Apr 15;35(6):325-6. Spanish. No abstract available. PMID: 15826518 [PubMed - indexed for MEDLINE]Related articlesFree article
The Vioxx debacle revisited.
Mohapatra PR, Janmeja AK.
Am J Med. 2005 Sep;118(9):1058. No abstract available. PMID: 16164909 [PubMed - indexed for MEDLINE]Related articles
Kim PS, Reicin AS.
Lancet. 2005 Jan 1-7;365(9453):23; author reply 26-7. No abstract available. PMID: 15639669 [PubMed - indexed for MEDLINE]Related articles
Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
Couzin J.
Science. 2005 Feb 25;307(5713):1183-5. No abstract available. PMID: 15731414 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...